Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn’s Disease. Takeda India, part of the Takeda Pharmaceutical Company Ltd., a global values-based…
Read More Takeda India Strengthens Patient Offering via Availability of Vedolizumab